Alphatec (ATEC) vs NovoCure (NVCR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
NovoCure (NVCR) has outperformed Alphatec (ATEC) over the past year, gaining 3.5% versus a loss of 23.8%. Over five years, ATEC leads with a -15.9% price change compared with -86.9% for NVCR. NovoCure is the larger company by market cap ($1.66 billion vs $1.60 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATEC | NVCR |
|---|---|---|
| Share price | $10.35 | $14.22 |
| Market cap | $1.60B | $1.66B |
| 1-day change | +0.98% | -3.00% |
| YTD return | -51.28% | +13.38% |
| 1-year return | -23.79% | +3.53% |
| 5-year return | -15.91% | -86.94% |
| Forward P/E | 17.24 | — |
| EPS (TTM) | $-0.72 | $-1.30 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $23.29 | $21.45 |
| 52-week low | $6.82 | $9.82 |
| Distance from 52-week high | -55.56% | -33.71% |
| Analyst consensus | none | buy |
| Avg. price target upside | +52.56% | +88.89% |
| Average volume | 2.14M | 1.42M |
| Shares outstanding | 154.45M | 116.45M |
| Employees | 913 | 1,605 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NVCR has outperformed ATEC by 27.3 percentage points over the past year.
About Alphatec
ATEC stock →Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts.
Health Care · Medical/Dental Instruments · 913 employees
About NovoCure
NVCR stock →NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax.
Health Care · Medical/Dental Instruments · 1,605 employees
ATEC vs NVCR FAQ
Which is bigger, Alphatec or NovoCure?
NovoCure (NVCR) is larger, with a market capitalization of $1.66B compared with $1.60B for Alphatec (ATEC).
Which stock has performed better over the past year, ATEC or NVCR?
NVCR returned +3.53% over the past 12 months, compared with -23.79% for ATEC (price return, excluding dividends). Past performance does not predict future results.
Are Alphatec and NovoCure in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.